Literature DB >> 1770751

Differential patterns of PMN-elastase and type III procollagen peptide in knee joint effusions due to acute and chronic sports injuries.

K A Riel1, M Jochum, P Bernett, H Fritz.   

Abstract

In 38 traumatic knee joint effusions the proteolytic enzyme PMN-elastase (PMN-E) and the repair marker procollagen III aminoterminal peptide (PIIINP) were determined. According to the period between trauma and first aspiration of the effusion, the patients were divided into 3 groups. Group I (17 patients; period between trauma and first aspiration not longer than 72 hours) showed high concentrations of PMN-E (up to 5400 ng/ml) and low concentrations of PIIINP (less than 13 U/ml). Group II (11 patients; aspiration within 4 to 14 days) had mean PMN-E and PIIINP concentrations of 125.6 ng/ml and 52.1 U/ml, respectively. In group III (10 patients, aspiration after 14 days) mean PMN-E concentration was 123.8 ng/ml and mean PIIINP concentration was 63.4 U/ml. Graphic depiction of PMN-E and PIIINP levels in each individual sample as a function of time between trauma and fluid collection revealed highly increasing PMN-E levels during the first 24 posttraumatic hours, followed by rapidly decreasing levels within 72 hours post trauma, and no change after the 4th posttraumatic day. In contrast, PIIINP increased continuously up to the first posttraumatic week and stayed at high levels up to 90 days (end of the observation period). The differential patterns of PMN-E and PIIINP concentration in knee joint effusions may be useful in estimating the period between trauma and first treatment (aspiration of effusion) and should, therefore, be helpful in detecting degenerative lesions, which seem to be characterized by low PMN-E concomitantly with high PIIINP levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1770751     DOI: 10.1007/bf01649454

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  22 in total

1.  Increased levels of proteoglycan fragments in knee joint fluid after injury.

Authors:  L S Lohmander; L Dahlberg; L Ryd; D Heinegård
Journal:  Arthritis Rheum       Date:  1989-11

2.  Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders.

Authors:  K Hørslev-Petersen; K D Bentsen; P Junker; F K Mathiesen; T M Hansen; I Lorenzen
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

Review 3.  Collagen: structure, function, and metabolism in normal and fibrotic tissues.

Authors:  M E Nimni
Journal:  Semin Arthritis Rheum       Date:  1983-08       Impact factor: 5.532

4.  Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro.

Authors:  E J Campbell; R M Senior; J A McDonald; D L Cox
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

5.  "PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor.

Authors:  S Neumann; G Gunzer; N Hennrich; H Lang
Journal:  J Clin Chem Clin Biochem       Date:  1984-10

6.  Direct effects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis.

Authors:  S E McGowan; J J Murray
Journal:  Am Rev Respir Dis       Date:  1987-06

Review 7.  [Biochemical and molecular biologic aspects of early detection of human arthroses].

Authors:  K von der Mark; K Glückert
Journal:  Orthopade       Date:  1990-02       Impact factor: 1.087

Review 8.  The aminopropeptide of collagen.

Authors:  R Timpl; R W Glanville
Journal:  Clin Orthop Relat Res       Date:  1981 Jul-Aug       Impact factor: 4.176

9.  Identification of collagen subtypes in synovial fluid sediments from arthritic patients.

Authors:  H S Cheung; L M Ryan; F Kozin; D J McCarty
Journal:  Am J Med       Date:  1980-01       Impact factor: 4.965

10.  The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.

Authors:  K Hørslev-Petersen; T Saxne; D Haar; B S Thomsen; K D Bentsen; P Junker; I Lorenzen
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.